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B cells and antibodies are essential for the protective immune response against a blood-stage Plasmodium infection. Although
extensive research has focused on memory as well as plasma B-cell responses during infection, little is known about how malaria
aﬀects B-cell development and splenic maturation into marginal zone B (MZB) and follicular B (FoB) cells. In this study, we show
that acute Plasmodium chabaudi AS infection in C57Bl/6 mice causes severe disruption of B lymphopoiesis in the bone marrow,
aﬀecting in particular pro-, pre-, and immature B cells as well as the expression of the bone marrow B-cell retention chemokine
CXCL12. In addition, elevated apoptosis of transitional T2 and marginal zone (MZ) B cells was observed during and subsequent
to the control of the first wave of parasitemia. In contrast, Folllicular (Fo) B cells levels were retained in the spleen throughout the
infection, suggesting that these are essential for parasite clearance and proper infection control.
1. Introduction
Malaria is a major health problem in developing countries,
aﬀecting each year at least 300–500 million individuals of
which more than 1 million people die of serious com-
plications. Primarily in children beyond 5 years, parasite-
mediated processes and excessive or uncontrolled inflam-
mation cause malaria pathogenesis, characterized by severe
malarial anemia (SMA), cerebral malaria (CM), malaria-
associated acute lung injury (ALI) and its more severe form
malaria-associated acute respiratory distress syndrome (MA-
ARDS) [1].
During a malaria infection, pre-erythrocytic liver stages
are mainly attacked by CD8+ eﬀector cells and IFN-γ,
whereas antibodies are key components against the asexual
blood stage of the Plasmodium life cycle [1, 2]. Studies in
mice lacking B cells revealed that they were unable to clear
a Plasmodium chabaudi AS (PcAS) infection and instead
displayed chronic unresolved parasitemia levels for periods
as long as 120 days [3]. Hence, B cells and malaria specific
antibodies are, in addition to CD4+T cells, required for
eﬀective antimalarial immunity [4–6]. Passive serum transfer
studies in human corroborate these findings [7, 8]. Despite
the key role of antibodies in immunity to malaria, there is a
gap in our knowledge on the cellular basis of these humoral
responses during infection. In malaria, several experimental
studies report that a single PcAS infection induces both
short-lived and long-lived plasma cells including the gen-
eration of functional memory B-cells [9–11]. In addition,
some recent human malaria studies report the generation
of long-lived plasma cells and memory B-cells, whether or
not in conditions of frequent re-exposure. However, Wykes
et al. revealed that Plasmodium yoelii is capable of destroying
vaccine-induced memory [12], suggesting defects in the B-
cell lineage might be induced during a malaria infection.
B-cell development of cells of the B2 lineage under
normal conditions occurs via a series of bone marrow
(BM) stromal cell-facilitated processes that begin within
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Figure 1: Parasitemia profile of PcAS infection. Course of malaria infection in C57Bl/6 mice infected with blood stages of PcAS. Data are
representative of at least 3 independent experiments with n > 10 for each experiment (mean ± SEM).
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Figure 2: B dyslymphopoiesis in bone marrow during PcAS infection. Bonemarrow cells from uninfected mice andmice infected with PcAS
for 10–41 days were stained for surface markers commonly used to define developing B cells and analyzed using FACS. Data are represented
as mean of three mice per group ± SEM, two independent repeat experiments were performed and statistics are compared to uninfected
controls (∗) P < .05, (∗∗) P < .01.
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Figure 3: Bone marrow CXCL12 mRNA expression during PcAS
infection. BM was isolated and amplified using intron-spanning
primers specific for CXCL12 via Quantitative PCR. Data were nor-
malized to S12 expression and are presented as relative expression
compared to uninfected controls. Data are represented as mean of
3 mice ± SEM and are representative of two separate experiments
were performed. (∗) P < .05, (∗∗) P < .01.
the hematopoietic stem cell pool and proceed in hierarchical
steps of lineage commitment [13, 14]. B lymphopoiesis
yields several developmental stages of pre-pro-B, pro-B, pre-
B and eventually immature B cells, which show a high
expression of the IgM form of the antigen receptor and low
or no expression of the IgD maturation marker [15, 16].
To complete their development, immature B cells migrate
through the periphery; however, only 10% reaches the spleen
as transitional B cells of the T1 type. Important is the fact that
under inflammatory immune conditions, BM lymphopoiesis
is often severely reduced and is compensated for by a
splenic cell diﬀerentiation process that involves the same
B-cell diﬀerentiation steps, referred to as extramedullary
lymphopoiesis [17, 18]. Once the transitional T1 stage has
been reached, B cells develop further into T2 transitional B
cells that in turn can mature into either Marginal Zone B
(MZB) cells or Follicular B (FoB) cells [19]. Each of these
populations is distinguished by a unique set of cell surface
antigens, allowing monoclonal antibody (mAb) phenotyping
by multicolor flow cytometry [20–22].
Although several studies have focused on analyzing the T-
and B-cell memory response inmurine models for malaria as
well as the plasma B-cell response, little is known about how a
Plasmodium infection aﬀects the process of B lymphopoiesis
in the bone marrow and the maturation into naive, resting
cells in the spleen. Recently, it has been reported that acute
PcAS infection induces the transient depletion of functional
myeloid-erythroid progenitors and loss of common lympho-
cyte progenitors (CLPs), which under normal circumstances
sustain both T- and B-cell development [23]. Because of the
essential protective role for B cells in blood-stage malaria,
it is important to understand the kinetics and regulation of
the whole B-cell cycle from development to diﬀerentiation
into plasma and memory B cells during infection. In this
study, we demonstrate that during the acute phase of a PcAS
infection B lymphopoiesis is severely compromised in the
bone marrow and infection-induced apoptosis of T2 and
MZB cells depletes these populations from the spleen. The
retention of splenic FoB cells in the spleen, being a source for
high-aﬃnity, parasite-specific-class-switched plasma B-cell
responses, is most likely essential for the proper parasitemia
clearance following the acute phase of infection. During the
chronic phase of infection, when parasitemia levels are low
and controlled, B lymphopoiesis in the bone marrow and
maturation into transitional T2 and MZB cells in the spleen
recovers completely and most likely this is crucial for the
further control of infection.
2. Material and Methods
2.1. Parasites and Infection in Mice. Male C57BL/6 wild
type (Janvier, Le Genest Saint-Isle, France; 6–8 weeks old)
were infected by intraperitoneal (i.p.) injection of blood
containing 104 PcAS infected red blood cells (iRBC) (a
kind gift of the late Professor Dr. D. Walliker, University of
Edingburgh, Scotland, UK). Parasitemia was analyzed using
Giemsa staining on a blood smear collected from the tail
vein during infection. All mice were housed under barrier
conditions and all experimental animal procedures were
approved by the appropriate university’s ethics committees.
2.2. Cell Isolation and Flow Cytometric Analysis. B-cell
populations were analyzed by flowcytometry. Both spleen
and bone marrow from femur and tibia were harvested from
noninfected control and PcAS infected mice 10, 20, 30 and
41 days postinfection (pi). Cell suspensions were prepared in
FACS buﬀer (1.0%BSA (Sigma, St. Louis,MO) inDPBS) and
red blood cells were lysed using lysis buﬀer (0.15M NH4Cl,
1.0mM KHCO3, 0.1mM Na2-EDTA). Nonspecific binding
sites were blocked using Fc block (CD16/CD32 Fcγ III/II,
BD biosciences, Erembodegem, Belgium) for 30minutes at
4◦C. Cells were washed twice with FACS buﬀer and stained
with biotin- or fluorochrome-conjugated primary antibodies
(Section 2.3) for 30 minutes at 4◦C. After washing twice,
cell suspensions stained with biotin-conjugated antibodies
were incubated with streptavidin-conjugated fluorochromes.
which detects cell bound biotinylated antibodies, and incu-
bated for an additional 30 minutes at 4◦C. Finally, cells
were resuspended in FACS buﬀer with 1 μg of 7-amino-
actinomycin D (7AAD), a fluorescent DNA dye that binds to
membrane permeable dead or dying cells, (BD biosciences).
Analyses were performed using a FACS Canto II flow
cytometer (BD Biosciences) and data were processed using
FLOWJO software (Tree Star Inc., Ashland, OR). The total
number of cells in each population was determined by
multiplying the percentages of subsets within a series of
marker negative or positive gates by the total cell number
determined for each tissue.
2.3. Antibodies and Detection Reagents. The following anti-
bodies were added to 100 μL aliquots of 106 Fc-blocked
leukocytes prepared as described above: 0.5 μg anti-CD23-
FITC (clone B3B4), 0.5 μg anti-IL7rα-FITC (clone A7R34),
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Figure 4: Extramedullary B lymphopoiesis in spleen during PcAS infection. Spleens cells from noninfected mice and mice infected with
PcAS for 10–41 days were stained for surface markers used to define developing B cells. The total B cell precursor population, including
pre-pro-B, pro-B, pre-B and immature B, was detected as 7AAD−Lin−B220intAA4.1hi using FACS. Data are representative of two separate
experiments.
0.5 μg anti-CD11b-FITC (clone M1/70; 0.5mg/mL), 0.5 μg
anti-CD45R (B220)-FITC (clone RA3-6B2), 0.2 μg anti-IgM-
PE (clone II/41), 0.2 μg anti-CD93–PE (clone AA4.1), 0.5 μg
anti-CD95-FITC (clone Jo2), 0.25 μg hamster IgG2, κ isotype
control (clone B81-3), 0.2 μg anti-IgM PE-Cy7 (clone II/41),
0.2 μg of anti-CD45R (B220)-PE-Cy7 (clone RA3-6B2),
0.2 μg of anti-CD93-APC (clone AA4.1), and 0.2 μg of anti-
CD117 (ckit)-APC (clone 2B8), purchased from eBioscience
(San Diego, CA); 0.2 μg anti-CD1d-PE (clone 1b1), 0.2 μg of
anti-CD43-PE (clone 1B11), 0.2 μg of anti-CD45R (B220)-
APC-Cy7 (clone RA3-6B2), 0.2 μg of anti-CD19-APC-Cy7
(clone 1D3), 0.2 μg of streptavidin-PerCP, and 0.2 μg of
streptavidin-PE-Texas Red, purchased from BD Biosciences
(Erembodegem, Belgium); 2 μg of each of the following
antibodies: CD3ε, CD11b (Mac-1), Gr-1 (Ly-6G and Ly-
6C) and Ter-119 (Ly-76) from the Biotin-conjugated Mouse
Lineage Panel (BD Biosciences, Erembodegem, Belgium).
2.4. Flow Cytometric Analyses of Apoptosis. Cells were stained
as described in Section 2.3 with antibodies. For the polycas-
pases-based apoptosis assay, labeled cells were further reacted
with the FLICA fluorescent inhibitor of caspase-1, -3, -4, -
5, -6, -7, -8, and -9, using the FAM Poly Caspases Assay Kit
for flow cytometric analysis (Molecular probes, Invitrogen,
Merelbeke, Belgium).
2.5. Statistical Analysis. Statistical comparisons were per-
formed by t-test or one way ANOVA and means were
compared using Tukey and Dunnett’s post test when P ≤ .05
(GraphPad Prism v.4.0, GraphPad Software Inc. San Diego,
CA).
3. Results
3.1. PcAS Infection Causes a Transient Suppression of B-Cell
Development in the Bone Marrow. To evaluate the kinetics
of the diﬀerent B-cell precursor populations in the bone
marrow during PcAS malaria, total bone marrow and spleen
cells were isolated from uninfected control mice and mice at
10, 20, 30, and 41 days pi and analyzed using flowcytometry
according to Table 1. Parasitemia wasmeasured as percentage
of parasitized red blood cells throughout infection and
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Figure 5: Depletion of transitional type 2 B cells in spleen during PcAS infection. (a) Spleens cells from noninfected mice and mice infected
with PcAS for 10–41 days were stained for surface markers commonly used to define transitional T2 B cells and analyzed using FACS. Data
are represented as mean of three mice per group ± SEM, two independent repeat experiments were performed and statistics are compared
to uninfected controls (∗∗) P < .01, (∗∗∗) P < .001. (b), (c), and (d) Transitional T2 B cells were detected as (AA4.1+B220+) IgM+CD23+ in
uninfected mice and mice on day 10 and 30 pi.
the representative profile is shown in Figure 1. At day 10
of infection, when parasitemia levels are about to peak,
there was a more than 95% depletion of all B-cell specific
precursor populations in the bone marrow. Afterwards, B-
cell lymphopoiesis slowly recovered until pre-pro-B, pro-B
and pre-B cell numbers are back to preinfection levels at day
41 pi (Figure 2).
The interaction between the chemokine CXCL12 and
its receptor CXCR4 on developing B cells is crucial for B
lymphopoiesis [14, 24], eliciting a stepwise progression of
developing B cells through specialized bone marrow niches
[25]. Here, we observed that a PcAS infection caused a sig-
nificant reduction in CXCL12 expression in the bonemarrow
on day 10 pi, which correlated with the observed reduction in
B-cell precursor cells at that time point. At days 20 and 30 of
infection, a significant recovery in CXCL12 expression was
measured in the bone marrow, coinciding with the observed
slow recovery of B lymphopoiesis (Figure 3). Furthermore,
when we analyzed the developing B cells in the bone marrow
of infected mice for apoptosis induction, there was no
diﬀerence with uninfected control mice (data not shown),
suggesting that apoptosis is not a major contributor to the
observed depletion of B-cell precursor populations in the
spleen.
Inflammation, characterized by high levels of TNF
and other type 1 cytokines, has a negative eﬀect on
bone marrow B-cell development. Induction of a reduced
CXCL12 ex-pression followed by migration of developing
B cells out of the bone marrow has been described to
coincide with the occurence of extramedullary B lym-
phopoiesis in the spleen [17, 18]. Here, on day 10 of a
PcAS infection, a distinct population of developing B cells
(pre-pro-, pro-, pre- and immature B cells defined here
together as 7AAD−, Lin−, AA4.1hi, B220+) was found in
the spleen, which was significantly increased compared to
uninfected controls (Figure 4). However, the number of
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Figure 6: PcAS infection-induced apoptosis of transitional B cells. Spleens cells from uninfected control mice and mice infected with PcAS
were stained for surface markers commonly used to define transitional T2 B cells and the amount of active caspase 1, -3, -4, -5, -6, -7, -8
and -9 was measured intracellular by flowcytometry. (a) Percentage of apoptotic cells within T2 transitional B-cell population in uninfected
controls versus infected mice on day 11 and 41 pi. Data are represented as mean of three mice per group ± SEM (∗∗∗) P < .001 and
representative of two separate experiments. (b) Representative histogram of uninfected controls (grey line) versus a day 11 pi (black line).
Table 1: Diﬀerentiation antigen phenotypes of developing and mature B2 B cells.
Cell population Suface marker phenotype
pre-pro-B Lin− (Ter119, CD3ε, CD11b, Gr1, NK1.1), B220+, AA4.1+, IgM−, CD19− , CD43hi
pro-B Lin− (Ter119, CD3ε, CD11b, Gr1, NK1.1), B220+, AA4.1+, IgM−, CD19+, CD43hi
pre-B Lin− (Ter119, CD3ε, CD11b, Gr1, NK1.1), B220+, AA4.1+, IgM−, CD19+, CD43lo/−
immature B Lin− (Ter119, CD3ε, CD11b, Gr1, NK1.1), B220+, AA4.1+, IgM+, CD19+, CD43lo/−
T1 transitional B220+, AA4.1+, IgMhi, CD23−
T2 transitional B220+, AA4.1+, IgMhi, CD23+
T3 transitional B220+, AA4.1+, IgMlo, CD23+
MZB B220+, AA4.1−, CD23lo, CD21hi, CD1dhi
FoB B220+, AA4.1−, CD23hi, CD21lo, CD1dlo
developing B cells in the spleen had diminished already
by day 20 pi and this population had disappeared com-
pletely by day 30 pi (Figure 4), which coincided with the
observed recovery of both CXCL12 expression (Figure 3)
and B-cell development in the bone marrow at that time
(Figure 2).
3.2. PcAS Malaria Results in Apoptosis of Transitional B Cells
in the Spleen. Transitional B cells form the cellular link
between the B-cell development in the bone marrow and the
maturation into mature marginal zone or follicular B cells
in the spleen. During PcAS infection in mice, a significant
decrease of T2 transitional B cells was observed on day 10 of
infection in the spleen, followed by a complete recovery on
day 20 pi. (Figure 5).
The induction of apoptosis was analyzed by measuring
the amount of active caspases inside the cell using flow
cytometry. Interestingly, about 80% of the T2 transitional
B-cell populations was triggered to undergo apoptosis on
day 11 pi. As a control, on day 41 of infection when T2 B-
cell numbers are no longer depleted, the level of apoptosis
induction had returned to preinfection level (Figure 6).
3.3. PcAS Infection Causes Apoptosis of Marginal Zone (MZ) B
Cells But Not Follicular (Fo) B Cells. Analysis of mice infected
with PcAS revealed that there was a more than 95% depletion
in MZB cells at days 10 and 20 of infection in the spleen,
followed by a strong recovery on day 30 pi. In contrast, there
was no significant decrease in FoB cell numbers during the
course of infection (Figure 7).
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Figure 7: Depletion of MZB but not FoB cells in spleen during PcAS infection. (a) and (b) Spleens cells from noninfected mice and mice
infected with PcAS for 10–41 days were stained for surface markers commonly used to define MZB (a) and FoB (b) cells and analyzed using
FACS. Data are represented as mean of three mice per group ± SEM, two independent repeat experiments were performed and statistics are
compared to uninfected controls (∗∗) P < .01. (c), (d), and (e) MZB and FoB cells were detected as (AA4.1−) B220+CD1d+ (CD23loCD21hi),
respectively, (AA4.1−) B220+CD1d− (CD23hiCD21lo), in noninfected mice and mice on day 10 and 30 pi.
Further analysis revealed that about 80% of theMZB cells
present in the spleen on day 11 of infection was undergoing
apoptosis (Figure 8). By day 41 of infection the level of
caspase activation had returned to preinfection levels, which
coincided with the observed recovery in MZB cell numbers
in the spleen at that time. In contrast, there was no increased
induction of FoB apoptosis during a PcAS infection.
4. Discussion
Polyclonal lymphocyte activation associated with spleno-
megaly, hypergamma-globulinemia and autoantibody pro-
duction are common features of Plasmodium infections in
both humans and experimental murine models. PcAS infec-
tions in mice are widely used as a model for P. falciparum
infections in humans. A primary infection is characterized
by parasitemia levels between 20–30% around day 10 of
infection, followed by a 2- to 3-month low-grade chronic
infection. Hence, this is an appropriate model to study
the immunological processes underlying the acquisition of
semi-immunity following a malaria infection [9]. Strong
innate and Th1 responses are related to the early stage of
infection and protection is believed to be associated with
IFN-γ, TNF and NO production. Around peak parasitemia
a switch to Th2 cytokine production occurs and the decline
in acute primary parasitemia and chronic stages of the
infection is controlled primarily in a B-cell and antibody-
dependent way [26–28]. The protective function of antibod-
ies during blood stage Plasmodium infection stretches from
being involved in the opsonization of merozoites and par-
asitized erythrocytes to the stimulation of macrophage and
neutrophil phagocytosis, parasite sequestration, and direct
merozoite neutralization [29, 30]. There is strong evidence
that naturally acquired immunity to blood-stage malaria
is strongly dependent on antibodies [29, 31–33]. However,
data from both experimental murine and human malaria
8 Journal of Parasitology Research
100
90
80
70
60
50
40
30
20
10
0
Uninfected Day 11pi Day 41pi
∗∗∗ ∗∗∗
A
po
pt
os
is
(%
)
MZB cells
(a)
100
90
80
70
60
50
40
30
20
10
0
Uninfected Day 11pi Day 41pi
A
po
pt
os
is
(%
)
FoB cells
(b)
MZB
83.4
100
80
60
40
20
0
1051041031020
M
ax
(%
)
Polycaspases
(c)
FoB
12.2
100
80
60
40
20
0
1051041031020
M
ax
(%
)
Polycaspases
(d)
Figure 8: PcAS infection-induced apoptosis of MZB but not FoB cells. Spleens cells from noninfected mice and mice infected with PcAS for
11 and 41 days were stained for surface markers commonly used to define MZB and FoB cells and the amount of active caspase 1, -3, -4, -5,
-6, -7, -8, and -9 was measured intracellular by flowcytometry. (a) and (b) Percentage of apoptotic cells within MZB or FoB cell population
in uninfected controls versus infected mice on day 11 and 41 pi. Data are represented as mean of three mice per group± SEM (∗∗∗) P < .001.
(c) and (d) Representative histogram of uninfected controls (grey line) versus a day 11 pi (black line).
show loss of activated or memory CD4+T cells, B cells and
plasma cells and short-lived malaria-specific antibodies after
a primary acute infection [28, 34–36]. Hence, it is possible
that the lack of eﬃcient, long lasting protective immunity
observed in human malaria is due to defects in the B-cell
lineage. Immunization and infection with Plasmodium or
other pathogens have already been described to transiently
suppress and/or alter bone marrow hematopoiesis, followed
by an increased migration of immature cells out of the bone
marrow, including RAG+ immature B cells [37]. In this
context, an increase in GL7-expressing cells was detected in
PBMC of PcAS infected mice and these cells also appeared to
be mainly immature B cells which had presumably migrated
from the bone marrow [38]. In agreement with this, we show
in this study that during an acute primary blood stage PcAS
infection, B-cell development is seriously impaired with a
more than 95% depletion of B-cell precursor cells in the
bone marrow. Later, when the acute first peak of infection
has been overcome and parasitemia remains below detection
levels, B lymphopoiesis slowly but surely recovers in the bone
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marrow. Loss of developing B cells from the bone marrow
has been correlated before with a reduction in bone marrow
CXCL12, resulting in a mobilization of developing B cells
to the periphery. In accordance with this, we report here
both a reduced CXCL12 production in the bone marrow
and an influx of developing B cells in the spleen during
the acute phase of infection. This premature migration out
of the bone marrow may reflect the physiologic process
for replenishing the transitional B-cell pool in the spleen,
but it actually results in a transient loss of bone marrow B
lymphopoiesis. The inflammatory cytokine TNF has been
reported to modulate B-cell development by reducing the
ability of the bone marrow to retain developing B cells.
([17], reviewed in [18]). In the serum of PcAS-infected
mice, TNF levels are very high around peak parasitemia
[39], so it is possible that a TNF-modulated reduction in
CXCL12 production in the bone marrow is contributing to
the observed impaired B lymphopoiesis.
It had already been described before that the majority
of apoptotic cells in the spleen of PcAS infected mice are B
cells, most likely comprising polyclonally activated B cells
through a mechanism that could possibly involve Fas [40].
Here, we show that a PcAS infection causes a severe depletion
of transitional T2 B cells and MZB cells in the spleen but
there is no significant change in FoB cell numbers during the
early stage of infection. The loss of transitional T2 and MZB
cells mainly results from the highly increased occurrence of
apoptosis in this population as about 80% of all T2 and
MZB cells are undergoing apoptosis in the acute phase of
infection. However, most likely MZB cells also serve as an
important source for T-cell independently generated IgM+
plasma B cells during the early stage of infection, seen that
parasite-specific IgM responses are already high around day
8 and peak at day 14 of infection [41]. In this context, it
can be speculated that by inducing massive MZB apoptosis,
the parasite is playing in its own advantage since protection
during an acute PcAS infection is (partially) dependent on
specific IgM and not natural IgM (mostly produced by
B-1 cells) [40]. In contrast, there is no infection-induced
apoptosis of FoB cells in the spleen. During PcAS infection
in mice, there are many class-switched plasma B cells found
in both peripheral blood and spleen, comprising mostly
IgG2a-secreting cells [42–45] that play an important role in
parasite clearance. Most likely the conservation of the FoB
cell pool during infection, being the major source for high-
aﬃnity malaria-specific class-switched plasma B cells, which
in turn are essential for parasite clearance, allows the mouse
to control the PcAS infection.
It is believed that periodic reinfection is necessary to
maintain acquired immunity to malaria and that Plasmod-
ium-specific antibodies are short lived in the absence of
reinfection, implying that the B-cell memory response to
malaria infection may be defective or suboptimal [1, 46].
However, the development and longevity of malaria-specific
B-cell memory is widely debated. Some studies have shown
that malaria infection interferes with the development of
long-lived plasma cells and memory B cells [35, 47, 48],
while others have demonstrated in both human infections
and animal models that isotype-switched memory B cells
do develop and are detectable for months or years in blood
and/or spleen [38, 46, 49]. However, persistence of memory
B cells in peripheral blood alone may not correlate with
longevity of specific humoral immunity. In this context,
in both malaria patients as well as murine models of
malaria, both short-lived [50, 51] and long-lived [49]
anti-Plasmodium antibody responses have been reported
in longitudinal and cross-sectional studies. However, in
the case of Plasmodium yoelii, infection-induced deletion
of vaccine-specific memory B cells as well as long-lived
plasma cells including those specific for bystander immune
responses have been described [12]. Hence, it can be specu-
lated that the prospects for developing an eﬀective vaccine
that is protective against human Plasmodium falciparum
or Plasmodium vivax infections are much better than for
African trypanosome infections, if further research clarifies
for several diﬀerent infection settings whether there is no
continuous destruction of immunological memory during
malaria infections or whether there is a situation similar to
the one observed for African trypanosome infections [52].
Taken together, our observations fit well with previous
studies and elucidate in detail the kinetics of B-cell devel-
opment and maturation during malaria infection, which
is essential for understanding the disease and the future
development of antimalaria vaccines.
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